GeneNews Ltd (TSE:GEN) shares were down 10.7% during mid-day trading on Wednesday . The stock traded as low as C$0.13 and last traded at C$0.13. Approximately 502,073 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 1,973,159 shares. The stock had previously closed at C$0.14.
The stock has a market capitalization of $23.80 million and a PE ratio of -3.68.
About GeneNews (TSE:GEN)
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Read More: What is a Fiduciary?
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.